Clinical Trial Update: Sonodynamic-Chemoradiotherapy Integration in Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sonodynamic-chemoradiotherapy integration for glioblastoma; enrollment is ongoing by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Yingjuan Zheng | Conditions: Glioblastoma (GBM) | Phase 2 | Status: ENROLLING_BY_INVITATION